These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15636484)

  • 1. The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls.
    Sterling TR
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1396-400. PubMed ID: 15636484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.
    Long R; Chong H; Hoeppner V; Shanmuganathan H; Kowalewska-Grochowska K; Shandro C; Manfreda J; Senthilselvan A; Elzainy A; Marrie T
    Clin Infect Dis; 2009 May; 48(10):1354-60. PubMed ID: 19348594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia.
    Yoon YS; Lee HJ; Yoon HI; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1215-9. PubMed ID: 16333927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis.
    Ginsburg AS; Hooper N; Parrish N; Dooley KE; Dorman SE; Booth J; Diener-West M; Merz WG; Bishai WR; Sterling TR
    Clin Infect Dis; 2003 Dec; 37(11):1448-52. PubMed ID: 14614666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.
    Dooley KE; Golub J; Goes FS; Merz WG; Sterling TR
    Clin Infect Dis; 2002 Jun; 34(12):1607-12. PubMed ID: 12032896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective.
    Low DE
    Clin Infect Dis; 2009 May; 48(10):1361-3. PubMed ID: 19348596
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoroquinolone use with no increase in culture-negative tuberculosis.
    Matsushima M; Yamamoto S; Iwata K; Gremillion DG
    Arch Intern Med; 2008 Sep; 168(16):1824-5; author reply 1825. PubMed ID: 18779473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigation of Mycobacterium tuberculosis sensitivity to fluoroquinolone, by revealing gyrA gene mutations].
    Nosova EIu; Galkina KIu; Markova OV; Griadunov DA; Skotnikova OI
    Probl Tuberk Bolezn Legk; 2007; (10):57-60. PubMed ID: 18051841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
    Gaba PD; Haley C; Griffin MR; Mitchel E; Warkentin J; Holt E; Baggett P; Sterling TR
    Arch Intern Med; 2007 Nov; 167(21):2317-22. PubMed ID: 18039990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.
    Grossman RF; Hsueh PR; Gillespie SH; Blasi F
    Int J Infect Dis; 2014 Jan; 18():14-21. PubMed ID: 24211230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.
    Agrawal D; Udwadia ZF; Rodriguez C; Mehta A
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):79-83. PubMed ID: 19105883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
    Bozeman L; Burman W; Metchock B; Welch L; Weiner M;
    Clin Infect Dis; 2005 Feb; 40(3):386-91. PubMed ID: 15668861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary tuberculosis presenting as community-acquired pneumonia.
    Asnis DS; Cherian S; Sun T; Shrestha S; Santucci T
    Clin Infect Dis; 2002 Dec; 35(12):1574-5. PubMed ID: 12471584
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
    Nseir S; Ader F; Marquette CH; Durocher A
    Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis.
    Chen TC; Lu PL; Lin CY; Lin WR; Chen YH
    Int J Infect Dis; 2011 Mar; 15(3):e211-6. PubMed ID: 21195001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.